Yahoo
OTC Markets OTCQB - Delayed Quote USD

Biotricity, Inc. (BTCY)

0.0560 +0.0039 (+7.49%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for BTCY
  • Previous Close 0.0521
  • Open 0.0515
  • Bid 0.0560 x 5000000
  • Ask 2,000.0000 x 3000000
  • Day's Range 0.0515 - 0.0600
  • 52 Week Range 0.0409 - 0.5900
  • Volume 97,161
  • Avg. Volume 46,205
  • Market Cap (intraday) 1.124M
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1300
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

www.biotricity.com

46

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BTCY
81.33%
S&P 500 (^GSPC)
7.76%

1-Year Return

BTCY
90.17%
S&P 500 (^GSPC)
9.77%

3-Year Return

BTCY
94.11%
S&P 500 (^GSPC)
68.96%

5-Year Return

BTCY
99.78%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.89M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-1M
0
1M
2M
3M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.41%

  • Return on Assets (ttm)

    16.24%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    16.4M

  • Net Income Avi to Common (ttm)

    -3.44M

  • Diluted EPS (ttm)

    -0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.77M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.36M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: